Ginwa Enterprise (Group) Inc.

¥3.98As of Sun 8 Nov 2026, 12:00 UTC
SSE:600080Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (10.34%)
Div yield 0.75%
ROE (3.51%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM —
TSR TTM (47.91%)
Mkt cap ¥1.419B
ROIC (0.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.12
28.55%
(94.30%)
Hold 1|12|7|3|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.05
0.05
11.15%
13.86%
21.48%
27.14%
Revenue¥M
112.1
114.4
112.9
115.1
3.39%
2.57%
(1.60%)
(0.45%)
Peers (US$212.7M)
Cap (US$)
PE
213.2M
14.37x
Capital
TTM
5Y
10Y
Leveragex
1.283
—
—
EBIT/Intx
1.225
0.876
0.822
Own earn%
(17.99)
81.37
59.75
Sh yield%
28.15
29.00
28.19
Owners
Insiders/Inst%
8.47
22.64
Short interest%
1.65
SBC / revenue%
5.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
2–10
$1 testx
−0.1
Incr. ROIC%
10